705 related articles for article (PubMed ID: 23224699)
21. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
22. Placental growth factor: a predictive marker for preeclampsia?
Schmidt M; Dogan C; Birdir C; Kuhn U; Gellhaus A; Kimmig R; Kasimir-Bauer S
Gynakol Geburtshilfliche Rundsch; 2009; 49(2):94-9. PubMed ID: 19346754
[TBL] [Abstract][Full Text] [Related]
23. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
Thadhani R; Ecker JL; Mutter WP; Wolf M; Smirnakis KV; Sukhatme VP; Levine RJ; Karumanchi SA
Hypertension; 2004 May; 43(5):988-92. PubMed ID: 15023932
[TBL] [Abstract][Full Text] [Related]
24. Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population.
Diguisto C; Le Gouge A; Piver E; Giraudeau B; Perrotin F
Prenat Diagn; 2013 Nov; 33(11):1070-4. PubMed ID: 23847040
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
26. Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset.
Meler E; Scazzocchio E; Peguero A; Triunfo S; Gratacos E; Figueras F
Prenat Diagn; 2014 Jul; 34(7):706-10. PubMed ID: 24752879
[TBL] [Abstract][Full Text] [Related]
27. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
Bian Z; Shixia C; Duan T
PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
[TBL] [Abstract][Full Text] [Related]
28. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.
Kusanovic JP; Romero R; Chaiworapongsa T; Erez O; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gotsch F; Edwin SS; Gomez R; Yeo L; Conde-Agudelo A; Hassan SS
J Matern Fetal Neonatal Med; 2009 Nov; 22(11):1021-38. PubMed ID: 19900040
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
30. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
31. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
32. Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
Fetal Diagn Ther; 2014; 35(4):249-57. PubMed ID: 24642536
[TBL] [Abstract][Full Text] [Related]
33. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
Muller PR; James AH; Murtha AP; Yonish B; Jamison MG; Dekker G
Hypertens Pregnancy; 2006; 25(3):183-92. PubMed ID: 17065039
[TBL] [Abstract][Full Text] [Related]
34. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
Asvold BO; Eskild A; Vatten LJ
Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
[TBL] [Abstract][Full Text] [Related]
36. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis.
Allen RE; Rogozinska E; Cleverly K; Aquilina J; Thangaratinam S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():194-201. PubMed ID: 25305662
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
38. Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia.
Lambert-Messerlian GM; Canick JA
Prenat Diagn; 2004 Nov; 24(11):876-80. PubMed ID: 15565562
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
[TBL] [Abstract][Full Text] [Related]
40. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]